1. Home
  2. ACGL vs ONC Comparison

ACGL vs ONC Comparison

Compare ACGL & ONC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACGL
  • ONC
  • Stock Information
  • Founded
  • ACGL 2001
  • ONC 2010
  • Country
  • ACGL Bermuda
  • ONC Switzerland
  • Employees
  • ACGL N/A
  • ONC N/A
  • Industry
  • ACGL Property-Casualty Insurers
  • ONC Biotechnology: Pharmaceutical Preparations
  • Sector
  • ACGL Finance
  • ONC Health Care
  • Exchange
  • ACGL Nasdaq
  • ONC Nasdaq
  • Market Cap
  • ACGL 34.5B
  • ONC 37.3B
  • IPO Year
  • ACGL 1995
  • ONC N/A
  • Fundamental
  • Price
  • ACGL $93.15
  • ONC $352.00
  • Analyst Decision
  • ACGL Buy
  • ONC Strong Buy
  • Analyst Count
  • ACGL 14
  • ONC 10
  • Target Price
  • ACGL $111.00
  • ONC $344.70
  • AVG Volume (30 Days)
  • ACGL 2.0M
  • ONC 230.5K
  • Earning Date
  • ACGL 10-27-2025
  • ONC 11-11-2025
  • Dividend Yield
  • ACGL 5.37%
  • ONC N/A
  • EPS Growth
  • ACGL N/A
  • ONC N/A
  • EPS
  • ACGL 9.67
  • ONC N/A
  • Revenue
  • ACGL $19,156,000,000.00
  • ONC $4,562,002,000.00
  • Revenue This Year
  • ACGL $3.34
  • ONC $881.07
  • Revenue Next Year
  • ACGL $5.81
  • ONC N/A
  • P/E Ratio
  • ACGL $9.62
  • ONC N/A
  • Revenue Growth
  • ACGL 23.80
  • ONC 47.33
  • 52 Week Low
  • ACGL $82.49
  • ONC $170.99
  • 52 Week High
  • ACGL $116.41
  • ONC $355.30
  • Technical
  • Relative Strength Index (RSI)
  • ACGL 62.81
  • ONC 62.34
  • Support Level
  • ACGL $88.77
  • ONC $334.53
  • Resistance Level
  • ACGL $91.06
  • ONC $355.30
  • Average True Range (ATR)
  • ACGL 1.58
  • ONC 6.98
  • MACD
  • ACGL 0.50
  • ONC 0.24
  • Stochastic Oscillator
  • ACGL 91.56
  • ONC 84.37

About ACGL Arch Capital Group Ltd.

Arch Capital Group Ltd is a Bermuda company that writes insurance and reinsurance with operations in the United States, Canada, Europe, Australia, and the United Kingdom. The business operates through three underwriting segments: insurance, reinsurance, and mortgage. The insurance segment provides specialty risk solutions to clients across various industries. The reinsurance segment provides reinsurance services which cover property catastrophe, property, liability, marine, aviation and space, trade credit and surety, agriculture, accident, life and health, and political risk. The mortgage business provides risk management and risk financing products to the mortgage insurance sectors through platforms in the U.S., Europe and Bermuda.

About ONC BeiGene Ltd. American Depositary Shares

Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.

Share on Social Networks: